Trials / Completed
CompletedNCT06586606
A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003)
A Two-Period Study to Evaluate the Effects of Multiple Oral Doses of Itraconazole on the Single Dose PK of MK-1708 in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The goal of the study is to see what happens to levels of MK-1708 a person's body over time. Researchers will compare what happens to MK-1708 in the body when it is given with or without a medicine called itraconazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-1708 | Oral administration |
| DRUG | Itraconazole | Oral administration |
Timeline
- Start date
- 2024-10-03
- Primary completion
- 2024-12-10
- Completion
- 2024-12-10
- First posted
- 2024-09-19
- Last updated
- 2024-12-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06586606. Inclusion in this directory is not an endorsement.